도소르비신을 포함한 CalliSpheres ® 약물 적재 마이크로스피어의 간세포 암종에서의 효능

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Treatment Strategy of Transarterial Chemoembolization for Hepatocellular Carcinoma2020 · 36 citations
2. 2Comparison of treatment efficacy and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres^® microspheres and conventional transarterial chemoembolization as first-line treatment in hepatocellular carcinoma patients.2019 · 35 citations
3. 3Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres® Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma2022 · 19 citations
4. 4Comparison of α-Fetoprotein Criteria and Modified Response Evaluation Criteria in Solid Tumors for the Prediction of Overall Survival of Patients with Hepatocellular Carcinoma after Transarterial Chemoembolization2018 · 24 citations
5. 5Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma2011 · 68 citations